Atherosclerosis and Lipid Management

Atherosclerosis remains a leading cause of heart attacks and strokes. This session will focus on advances in lipid-lowering therapies, including the latest in statins, PCSK9 inhibitors, and gene editing technologies. Discussions will also cover lifestyle interventions and imaging techniques for assessing atherosclerotic plaque burden.

    Related Conference of Atherosclerosis and Lipid Management

    December 09-10, 2024

    3rd International Conference on Cardiology

    Dubai, UAE
    December 10-11, 2024

    6th Euro Cardiology Congress

    Dubai, UAE
    December 12-13, 2024

    13th World Heart Congress

    Rome, Italy
    December 12-13, 2024

    5th Global Summit on Heart Congress

    Dubai, UAE
    December 26-27, 2024

    28th World Cardiology Conference

    Paris, France
    February 20-21, 2025

    14th World Congress on Cardiology

    Amsterdam, Netherlands
    February 20-21, 2025

    35th International Conference on Cardiology and Healthcare

    Amsterdam, Netherlands
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    February 27-28, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    March 24-25, 2025

    14th World Heart Congress

    Paris, France
    April 16-17, 2025

    8th World Heart and Brain Conference

    Tokyo, Japan
    April 24-25, 2025

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Atherosclerosis and Lipid Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in